DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.
about
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant RecipientsHLA Mismatching Strategies for Solid Organ Transplantation - A Balancing ActHLA-DQ Mismatches and Rejection in Kidney Transplant RecipientsBetter understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection.Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation.Clinically relevant interpretation of solid phase assays for HLA antibody.De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients.Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation.HLA-DQ Mismatching: Mounting Evidence for a Role in Kidney Transplant Rejection.Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.Clinical and histopathologic features of antibody-mediated rejection among pediatric renal transplant recipients with preformed vs de novo donor-specific antibodies.Kidney Intragraft Homing of De Novo Donor-Specific HLA Antibodies Is an Essential Step of Antibody-Mediated Damage but Not Per Se Predictive of Graft Loss.Preexisting anti-HLA donor-specific antibodies in pediatric renal transplant recipients - A new challenge?
P2860
Q26774993-320C33C6-ED57-4A78-86A1-D64C0B691979Q28074462-8982E24D-9F57-43CA-AE1F-A097D4928D53Q36874597-E07DB4D0-0533-4985-9D90-B8F193986AD6Q38282840-A648D8E6-0EFC-4140-9C5E-397AD55FCFB8Q38674466-58D873DF-C3D6-4996-AB2A-DE0525828A37Q38839248-F93BC2B2-4FD1-4FA6-8D83-4FA0AF4B6A6EQ38861456-62B60037-E872-4370-8864-CAC599C5B56EQ42700183-9C3A1107-AA86-44EA-B481-F48CAB6C092BQ42824238-457DBE1B-4DAB-46FA-B7FA-42EC72A28180Q46516137-D1757D67-2C27-4DFF-A39D-4CBBD298E5C8Q47574733-615B6EFC-FE1C-4616-A008-8C844AE9F492Q51585363-47F6AEA9-047B-45EB-B4F6-9942E72FD750Q52842569-E2A4D6EA-9791-48C7-9101-0107D9442108
P2860
DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
DQ molecules are the principal ...... ing a first kidney transplant.
@en
DQ molecules are the principal ...... ing a first kidney transplant.
@nl
type
label
DQ molecules are the principal ...... ing a first kidney transplant.
@en
DQ molecules are the principal ...... ing a first kidney transplant.
@nl
prefLabel
DQ molecules are the principal ...... ing a first kidney transplant.
@en
DQ molecules are the principal ...... ing a first kidney transplant.
@nl
P2093
P2860
P50
P356
P1476
DQ molecules are the principal ...... ving a first kidney transplant
@en
P2093
Alberto Magnasco
Antonella Trivelli
Arcangelo Nocera
Augusto Tagliamacco
Caterina Brambilla
Domenico Palombo
Fabrizio Ginevri
Iris Fontana
Massimo Cardillo
Miriam Ramondetta
P2860
P304
P356
10.1111/TRI.12316
P577
2014-04-25T00:00:00Z